AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Eglucent Mix 50 Kwikpen 100IU/ml

Prescription Icon
Prescription Required

Marketer

Lupin Ltd

Salt Composition

Insulin Lispro (50%) + Insulin Lispro Protamine (50%)

Overview Eglucent Mix 50 Kwikpen 100IU/ml

InsuLinMix 50 Kwikpen (100 IU/ml) combines two medications to effectively manage blood glucose in individuals with type 1 and type 2 diabetes. This rapid-acting insulin lowers post-meal blood sugar, mitigating the risk of diabetes-related complications. InsuLinMix 50 Kwikpen is usually administered alongside a long-acting insulin or other diabetic medications. Proper subcutaneous injection technique will be demonstrated by your healthcare provider. Injection should occur 15 minutes before or within 20 minutes after meal initiation. Discontinue use only under your doctor's guidance. This medication forms part of a comprehensive treatment plan encompassing a healthy diet, regular physical activity, and weight management as recommended by your doctor. Regular blood glucose monitoring, record-keeping, and result sharing with your doctor are crucial for optimal dose adjustment. Hypoglycemia (low blood sugar) is the most frequent adverse effect. Consistent dosing, regular meals, and blood sugar monitoring help prevent this. Excessive alcohol consumption can also induce hypoglycemia. Injection site reactions, such as redness, swelling, or lipodystrophy (hard lumps), may occur. Itching and rash are also possible. Avoid use if hypoglycemic. Inform your doctor of any pre-existing kidney, liver, or heart conditions before commencing treatment. Pregnant or breastfeeding individuals should consult their doctor for potential dose modifications.

Primary Ingredients of Eglucent Mix 50 Kwikpen 100IU/ml

The provided text is "undefined," therefore, no rephrasing is possible.

Uses of Eglucent Mix 50 Kwikpen 100IU/ml

High blood sugar

Major Benefits of Eglucent Mix 50 Kwikpen 100IU/ml:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

Common Side effects of Eglucent Mix 50 Kwikpen 100IU/ml:

  • Weight gain
  • Infusion site reaction
  • Hypoglycemia (low blood glucose level)
  • Edema (swelling)
  • Skin rash

How to use Eglucent Mix 50 Kwikpen 100IU/ml:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Eglucent Mix 50 Kwikpen 100IU/ml works:

Kwikpen Eglucent Mix 50, a 100 IU/mL solution, combines two distinct insulin formulations.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Eglucent Mix 50 Kwikpen 100IU/ml and alcohol is inadvisable due to safety concerns.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Eglucent Mix 50 Kwikpen (100 IU/ml) during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.

Breast feedingBreast feedingCAUTION

The use of Eglucent Mix 50 Kwikpen 100 IU/ml warrants caution while breastfeeding. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.

DrivingDrivingCAUTION

Driving may be impaired by both excessively high and low blood glucose levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Eglucent Mix 50 Kwikpen (100 IU/ml). Dosage modification of Eglucent Mix 50 Kwikpen (100 IU/ml) may be necessary. Physician consultation is advised. Routine blood glucose level checks are recommended to guide dosage adjustments.

LiverLiverCAUTION

Patients with liver impairment should use Eglucent Mix 50 Kwikpen 100IU/ml cautiously, potentially requiring dosage modification. Physician consultation is advised. Routine glucose level checks are recommended to guide dosage adjustments.

What if you forget to take Eglucent Mix 50 Kwikpen 100IU/ml :

Failure to administer a scheduled dose of Eglucent Mix 50 Kwikpen 100 IU/ml may result in elevated blood glucose (hyperglycemia). Monitor your blood sugar levels and adjust subsequent dosing as needed.

Facts to Know About Eglucent Mix 50 Kwikpen 100IU/ml

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Eglucent Mix 50 Kwikpen 100IU/ml

Before injecting, wash your hands thoroughly. Select an injection site and clean the skin according to instructions. Remove the needle cap. Gently spread or pinch the skin to stabilize the injection area. Insert the needle as directed, then depress the plunger. Withdraw the needle and apply gentle pressure for a few seconds; avoid rubbing. Safely dispose of the needle using the provided cap, unscrewing it first. Rotate injection sites, using each no more than once monthly.
Before each use, gently roll the insulin device between your palms ten times and invert it 180° ten times to ensure the insulin is thoroughly mixed and uniformly cloudy or milky. Repeat if necessary. Avoid vigorous shaking to prevent frothing. Discard the device if clumps or solid white particles are visible inside the cartridge, giving it a frosted appearance.
Yes, priming your pen is necessary. Insufficient priming may result in inaccurate insulin delivery. To prime, set the dose to 2 units. Hold the pen vertically with the needle pointing upwards, gently tapping the cartridge to bring air bubbles to the top. Keep the pen vertical. Fully depress the dose knob until '0' appears in the dose window. Hold for a 5-second count. Insulin should then be visible at the needle tip.
Slower injection is achieved by turning the dose knob more gradually. A blocked needle may be the cause; replace the needle and re-prime the pen.
Hypoglycemia, or low blood sugar, is the most frequent side effect, potentially causing fatigue, confusion, rapid heartbeat, headache, sweating, and vomiting. Always have readily available fast-acting sugar, like glucose tablets, hard candy, or juice, to counter low blood sugar. Insulin should not be used during hypoglycemic episodes. Serious, potentially fatal allergic reactions and injection site reactions are also possible.
Should you experience any side effects, contact your physician.
Certain medications can raise blood sugar levels, increasing insulin needs. These include corticosteroids, isoniazid, some lipid-lowering drugs (like niacin), estrogens, oral contraceptives, phenothiazines, and thyroid hormone replacement.
Lower insulin doses may be needed when using medications that enhance insulin's effects or lower blood sugar. These include oral diabetes drugs, salicylates, sulfa antibiotics, some antidepressants (MAO inhibitors), ACE inhibitors, angiotensin II receptor blockers, beta-blockers, pancreatic function inhibitors (like octreotide), and alcohol. Beta-blockers can also mask hypoglycemia symptoms in certain individuals.
Extensive data show no harmful effects of insulin lispro (Eglucent Mix 50 Kwikpen's main component) on pregnancy or fetal/newborn health. Insulin needs typically decrease in the first trimester and rise in the second and third. Diabetic women should consult their doctor about pregnancy or pregnancy plans. Close monitoring of blood sugar and overall health is crucial during pregnancy for diabetic patients. Breastfeeding diabetic patients may need insulin dose, dietary, or combined adjustments.
Eglucent Mix 50 Kwikpen 1...
1,129
MRP 1,244
9% off